胰岛素抵抗是没有2型糖尿病的高血压成年人心血管风险因素
Rafael Garcia-Carretero1, Oscar Vazquez-Gomez2, Ruth Gil-Prieto3
1Department of Internal Medicine, Mostoles University Hospital, Rey Juan Carlos University (Madrid), Calle Rio Jucar, s/n, 28935, Mostoles (Madrid), Spain. rgcarretero@salud.madrid.org.
Wiener klinische Wochenschrift
|October 9, 2023
概括
胰岛素抵抗和肥胖是心血管风险的关键指标,在没有糖尿病的高血压患者. 测量胰岛素耐药性可以预测高风险患者的心血管事件.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 代谢综合征涉及肥胖,脂质不良,高血糖和高血压,增加心血管风险和2型糖尿病风险.
- 胰岛素抵抗是代谢综合征的潜在机制,但其与心血管风险的直接联系尚不清楚.
- 高血压是主要的心血管风险因素,经常与代谢异常共存.
研究的目的:
- 调查胰岛素抵抗与心血管风险增加之间的联系.
- 在没有糖尿病的高血压成年人中评估心血管风险.
- 为了确定在门诊环境中对胰岛素抵抗的预测值.
主要方法:
- 对没有糖尿病的高血压成年人进行了回顾性纵向研究.
- 收集了人口,临床和实验室参数,包括血胰岛素和HOMA-IR.
- 利用后勤回归和考克斯比例危险模型来分析心血管事件.
主要成果:
- 胰岛素抵抗 (HOMA-IR) 和体重指数是心血管事件的独立预测指标.
- 较高的HOMA-IR (HR 1.4) 和BMI (HR 1.05) 与心血管风险增加有显著关联.
- 男性性别,高LDL和功能在后勤回归中相关,但在生存分析中没有相关性.
结论:
- 胰岛素耐药性和肥胖症对于在没有糖尿病且功能保持的高血压患者中评估心血管风险非常有价值.
- 测量胰岛素抵抗可以预测高风险门诊患者群体的心血管事件.
- 这项研究强调了评估胰岛素抵抗在心血管风险分层中的临床有用性.
相关概念视频
Hypertension I: Introduction
14
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
14
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Hypertension III: Clinical Manifestations and Diagnostic Studies
15
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
15
Diabetes: Symptoms, Diagnosis, and Complications
557
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
557
Hypertension II: Pathophysiology
14
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
14
Coronary Artery Disease I: Introduction
17
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17


